Trustmark National Bank Trust Department’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,729
Closed -$233K 235
2019
Q3
$233K Sell
5,729
-91
-2% -$3.85K 0.02% 219
2019
Q2
$250K Buy
5,820
+398
+7% +$15.3K 0.02% 213
2019
Q1
$208K Buy
5,422
+3,869
+249% +$148K 0.02% 226
2018
Q4
$55K Hold
1,553
0.01% 321
2018
Q3
$60K Buy
+1,553
New +$54.2K 0.01% 340
2016
Q2
Sell
-10,327
Closed -$194K 298
2016
Q1
$194K Buy
10,327
+163
+2% +$2.86K 0.03% 307
2015
Q4
$188K Buy
+10,164
New +$182K 0.03% 308

Other funds holding BSX

Trustmark National Bank Trust Department's BSX Position: Q4 2019 in Review

Trustmark National Bank Trust Department sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 5,729 shares — an estimated $233K sold.

Trustmark National Bank Trust Department first reported a position in BSX in Q4 2015 and held it in 7 quarters. The position peaked at $250K in Q2 2019. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Trustmark National Bank Trust Department reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 5,729 Boston Scientific shares in Q4 2019, an estimated $233K.
  • Trustmark National Bank Trust Department first reported a position in Boston Scientific in Q4 2015 and held it in 7 quarters.
  • Trustmark National Bank Trust Department's Boston Scientific position peaked at $250K in Q2 2019.
  • 854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2019, filed 14 Feb 2020.